Karlan BY - Search Results

1

ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma.

Cheon DJ, Li AJ, Beach JA, Walts AE, Tran H, Lester J, Karlan BY, Orsulic S. Cheon DJ, et al. Among authors: karlan by. Carcinogenesis. 2015 Jul;36(7):739-47. doi: 10.1093/carcin/bgv059. Epub 2015 Apr 29. Carcinogenesis. 2015. PMID: 25926422 Free PMC article.

2

Steroid hormonal independence of HER-2/neu mRNA expression in four human ovarian carcinoma cell lines.

Jones J, Lagasse LD, Karlan BY. Jones J, et al. Among authors: karlan by. Gynecol Oncol. 1994 Dec;55(3 Pt 1):421-6. doi: 10.1006/gyno.1994.1316. Gynecol Oncol. 1994. PMID: 7835782

3

Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma.

Bristow RE, Baldwin RL, Yamada SD, Korc M, Karlan BY. Bristow RE, et al. Among authors: karlan by. Cancer. 1999 Feb 1;85(3):658-68. doi: 10.1002/(sici)1097-0142(19990201)85:3<658::aid-cncr16>3.0.co;2-m. Cancer. 1999. PMID: 10091739

4

Primary ovarian cancer cultures are resistant to Fas-mediated apoptosis.

Baldwin RL, Tran H, Karlan BY. Baldwin RL, et al. Among authors: karlan by. Gynecol Oncol. 1999 Aug;74(2):265-71. doi: 10.1006/gyno.1999.5448. Gynecol Oncol. 1999. PMID: 10419743

5

Ovarian carcinoma cell cultures are resistant to TGF-beta1-mediated growth inhibition despite expression of functional receptors.

Yamada SD, Baldwin RL, Karlan BY. Yamada SD, et al. Among authors: karlan by. Gynecol Oncol. 1999 Oct;75(1):72-7. doi: 10.1006/gyno.1999.5535. Gynecol Oncol. 1999. PMID: 10502429

6

BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.

Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY. Baldwin RL, et al. Among authors: karlan by. Cancer Res. 2000 Oct 1;60(19):5329-33. Cancer Res. 2000. PMID: 11034065

7

Genetic factors in ovarian carcinoma.

Li AJ, Karlan BY. Li AJ, et al. Among authors: karlan by. Curr Oncol Rep. 2001 Jan;3(1):27-32. doi: 10.1007/s11912-001-0039-y. Curr Oncol Rep. 2001. PMID: 11123866 Review.

8

Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas.

Cass I, Li AJ, Runowicz CD, Fields AL, Goldberg GL, Leuchter RS, Lagasse LD, Karlan BY. Cass I, et al. Among authors: karlan by. Gynecol Oncol. 2001 Jan;80(1):56-61. doi: 10.1006/gyno.2000.6027. Gynecol Oncol. 2001. PMID: 11136570

9

Chemotherapy in epithelial ovarian cancer.

Wang J, Li AJ, Karlan BY. Wang J, et al. Among authors: karlan by. Curr Womens Health Rep. 2002 Feb;2(1):20-6. Curr Womens Health Rep. 2002. PMID: 12112979 Review.

10

Gene expression in epithelial ovarian carcinoma.

Matei D, Graeber TG, Baldwin RL, Karlan BY, Rao J, Chang DD. Matei D, et al. Among authors: karlan by. Oncogene. 2002 Sep 12;21(41):6289-98. doi: 10.1038/sj.onc.1205785. Oncogene. 2002. PMID: 12214269

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

519 results

Search Page

Filters